Fig. 5From: Efficacy of first-line treatments in the elderly and non-elderly patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: a network meta-analysisBayesian ranking profiles of comparable treatments on efficacy for patients with non-small cell lung cancer. Profiles indicate the probability of each comparable treatment being ranked from first to last on progression free survival (PFS), overall survival (OS)Back to article page